Kura Oncology to Report First Quarter 2025 Financial Results
SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed...
Cancer
SEED Therapeutics Reports Breakthroughs for Two Targeted Protein Degradation Projects at AACR Annual Meeting in Chicago
Two PROTAC synergy using two E3 ligases for achieving levels of degradation of KRAS G12D not achieved with single PROTACs,...
Avidicure Launches with $50 Million in Seed Financing to Develop New Multifunctional Antibody Modality to Treat Cancer
AVC-Boosters are designed as dual agonistic antibodies to safely deliver targeted and potent monotherapy with broad application in oncology Lead...
Labroots Open-Access Scientific Virtual Event Lineup: Spring 2025
YORBA LINDA, Calif., April 23, 2025 /PRNewswire/ -- Labroots, the leading scientific social networking website offering preeminent, interactive virtual and...
SimonMed Imaging Partners with Lunit to Deliver Best-in-Class AI for Breast Cancer Detection
A Major Leap Forward in Patient Health and the Future of Mammography PHOENIX, April 23, 2025 /PRNewswire/ -- SimonMed Imaging®,...
MammoScreen Breast AI Adopted by Mayo Clinic for Radiology Use
CHICAGO and PARIS, April 23, 2025 /PRNewswire/ -- Therapixel, the developer of MammoScreen, an AI-based breast cancer screening software, announces...
MammoScreen Breast AI Adopted by Mayo Clinic for Radiology Use
CHICAGO and PARIS, April 23, 2025 /PRNewswire/ -- Therapixel, the developer of MammoScreen, an AI-based breast cancer screening software, announces...
Nikon Instruments Announces Opening of Newest Nikon Center of Excellence at the University of Arizona Cancer Center
MELVILLE, N.Y., April 23, 2025 /PRNewswire/ -- Today, Nikon Instruments Inc. announced the opening of its newest Nikon Center of Excellence imaging facility...
Nikon Instruments Announces Opening of Newest Nikon Center of Excellence at the University of Arizona Cancer Center
MELVILLE, N.Y., April 23, 2025 /PRNewswire/ -- Today, Nikon Instruments Inc. announced the opening of its newest Nikon Center of Excellence imaging facility...
OncoHost to Showcase Plasma Proteomics Research in NSCLC at AACR 2025
New Data Sheds Light on Mechanisms of Immunotherapy Resistance and Supports Development of Personalized Treatment Strategies BINYAMINA, Israel and CARY,...
OncoHost to Showcase Plasma Proteomics Research in NSCLC at AACR 2025
New Data Sheds Light on Mechanisms of Immunotherapy Resistance and Supports Development of Personalized Treatment Strategies BINYAMINA, Israel and CARY,...
Cortechs.ai Receives Health Canada Approval to Expand Sales of AI-Powered Imaging Solutions in North America
SAN DIEGO, April 23, 2025 /PRNewswire/ -- Cortechs.ai, a global leader in AI-driven medical imaging analysis, is proud to announce...
Dovetail Genomics Unveils Ultra-Sensitive Somatic Variant Detection and AI-Driven Analysis Ahead of AACR 2025
SCOTTS VALLEY, Calif., April 23, 2025 /PRNewswire/ -- Dovetail Genomics, a leading innovator in genomic solutions, today announced an expanded...
Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting
MINNEAPOLIS, April 23, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its latest advancements in cancer...
BioAtla Announces Upcoming Poster Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the...
Adagene Announces Upcoming Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at American Society of Clinical Oncology (ASCO) Annual Meeting
SAN DIEGO and SUZHOU, China, April 23, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the...
Immix Biopharma’s NXC-201 NEXICART-2 Clinical Trial Data Selected for Oral Presentation at ASCO 2025
— Oral presentation Tuesday, June 3, 2025 in Chicago — LOS ANGELES, April 23, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma,...
Bicara Therapeutics to Present Updated Data from Ongoing Phase 1/1b Trial of Ficerafusp alfa in 1L R/M HNSCC at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative...
Merus Announces Abstract Accepted for Presentation at the 2025 ASCO® Annual Meeting
- Petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC interim clinical data selected for poster presentation - Conference...
Immatics Announces Upcoming Oral and Poster Presentation on IMA203 TCR T-cell Therapy at 2025 ASCO Annual Meeting
Houston, Texas and Tuebingen, Germany, April 23, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company...